INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,070 | -12.9% | 2,750 | 0.0% | 0.00% | – |
| Q2 2023 | $1,228 | -45.5% | 2,750 | 0.0% | 0.00% | – |
| Q1 2023 | $2,255 | -47.4% | 2,750 | 0.0% | 0.00% | – |
| Q4 2022 | $4,290 | -14.2% | 2,750 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -50.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | -28.6% | 2,750 | 0.0% | 0.00% | – |
| Q4 2021 | $14,000 | -30.0% | 2,750 | 0.0% | 0.00% | – |
| Q3 2021 | $20,000 | -20.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2021 | $25,000 | -3.8% | 2,750 | 0.0% | 0.00% | – |
| Q1 2021 | $26,000 | +8.3% | 2,750 | 0.0% | 0.00% | – |
| Q4 2020 | $24,000 | -25.0% | 2,750 | 0.0% | 0.00% | – |
| Q3 2020 | $32,000 | -56.8% | 2,750 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $74,000 | +270.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2020 | $20,000 | +122.2% | 2,750 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | +50.0% | 2,750 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -25.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -20.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2019 | $10,000 | -9.1% | 2,750 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -26.7% | 2,750 | 0.0% | 0.00% | – |
| Q3 2018 | $15,000 | +36.4% | 2,750 | 0.0% | 0.00% | – |
| Q2 2018 | $11,000 | -15.4% | 2,750 | 0.0% | 0.00% | – |
| Q1 2018 | $13,000 | +18.2% | 2,750 | 0.0% | 0.00% | – |
| Q4 2017 | $11,000 | -42.1% | 2,750 | 0.0% | 0.00% | – |
| Q4 2016 | $19,000 | -26.9% | 2,750 | 0.0% | 0.00% | – |
| Q3 2016 | $26,000 | +4.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2016 | $25,000 | +4.2% | 2,750 | 0.0% | 0.00% | – |
| Q1 2016 | $24,000 | +33.3% | 2,750 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | +12.5% | 2,750 | 0.0% | 0.00% | – |
| Q3 2015 | $16,000 | -27.3% | 2,750 | 0.0% | 0.00% | – |
| Q2 2015 | $22,000 | 0.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2015 | $22,000 | -12.0% | 2,750 | 0.0% | 0.00% | – |
| Q4 2014 | $25,000 | -7.4% | 2,750 | 0.0% | 0.00% | – |
| Q3 2014 | $27,000 | -10.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2014 | $30,000 | – | 2,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |